These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17259924)

  • 1. Fenretinide and risk reduction of second breast cancer.
    Decensi A; Zanardi S; Argusti A; Bonanni B; Costa A; Veronesi U
    Nat Clin Pract Oncol; 2007 Feb; 4(2):64-5. PubMed ID: 17259924
    [No Abstract]   [Full Text] [Related]  

  • 2. [-Results of ongoing breast cancer prevention studies-].
    Jungi WF
    Arch Gynecol Obstet; 1995; 256 Suppl():S116-21. PubMed ID: 8619644
    [No Abstract]   [Full Text] [Related]  

  • 3. Fenretinide breast cancer prevention trial: drug and retinol plasma levels in relation to age and disease outcome.
    Formelli F; Camerini T; Cavadini E; Appierto V; Villani MG; Costa A; De Palo G; Di Mauro MG; Veronesi U
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):34-41. PubMed ID: 12540501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.
    Ménard S; Camerini T; Mariani L; Tomasic G; Pilotti S; Costa A; De Palo G; Veronesi U
    J Natl Cancer Inst; 2001 Feb; 93(3):240-1. PubMed ID: 11158198
    [No Abstract]   [Full Text] [Related]  

  • 5. Surrogate response biomarkers in prevention research: do they point the way or lead us astray?
    Fabian CJ
    J Clin Oncol; 2009 Aug; 27(23):3734-6. PubMed ID: 19597020
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemoprevention of breast cancer with fenretinide.
    Veronesi U; De Palo G; Costa A; Formelli F; Decensi A
    IARC Sci Publ; 1996; (136):87-94. PubMed ID: 8791119
    [No Abstract]   [Full Text] [Related]  

  • 7. Vitamin A analogue for breast cancer prevention: a grade of F or incomplete?
    Piantadosi S
    J Natl Cancer Inst; 1999 Nov; 91(21):1794. PubMed ID: 10547379
    [No Abstract]   [Full Text] [Related]  

  • 8. Ductal carcinoma in situ: a window of opportunity?
    Temple WJ
    Can J Surg; 1992 Aug; 35(4):337-8. PubMed ID: 1323378
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.
    Veronesi U; De Palo G; Marubini E; Costa A; Formelli F; Mariani L; Decensi A; Camerini T; Del Turco MR; Di Mauro MG; Muraca MG; Del Vecchio M; Pinto C; D'Aiuto G; Boni C; Campa T; Magni A; Miceli R; Perloff M; Malone WF; Sporn MB
    J Natl Cancer Inst; 1999 Nov; 91(21):1847-56. PubMed ID: 10547391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide.
    Costa A; Formelli F; Chiesa F; Decensi A; De Palo G; Veronesi U
    Cancer Res; 1994 Apr; 54(7 Suppl):2032s-2037s. PubMed ID: 8137334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic retinoid fenretinide in breast cancer chemoprevention.
    Bonanni B; Lazzeroni M; Veronesi U
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):423-32. PubMed ID: 17428163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fenretinide on ovarian carcinoma occurrence.
    De Palo G; Mariani L; Camerini T; Marubini E; Formelli F; Pasini B; Decensi A; Veronesi U
    Gynecol Oncol; 2002 Jul; 86(1):24-7. PubMed ID: 12079295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer chemoprevention: additional observations.
    Singh-Ranger G; Mokbel K
    Int J Clin Pract; 2003 Mar; 57(2):155; author reply 155. PubMed ID: 12661805
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of special types of breast cancer].
    Koszarowski T; Klein A
    Pol Tyg Lek; 1968 Jun; 23(25):948-50. PubMed ID: 4299341
    [No Abstract]   [Full Text] [Related]  

  • 15. Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer.
    Veronesi U; Mariani L; Decensi A; Formelli F; Camerini T; Miceli R; Di Mauro MG; Costa A; Marubini E; Sporn MB; De Palo G
    Ann Oncol; 2006 Jul; 17(7):1065-71. PubMed ID: 16675486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extremely early onset hereditary breast cancer (HBC): surveillance/management implications.
    Lynch HT; Conway T; Watson P; Schreiman J; Fitzgibbons RJ
    Nebr Med J; 1988 Apr; 73(4):97-100. PubMed ID: 2835693
    [No Abstract]   [Full Text] [Related]  

  • 17. Fenretinide in the prevention of breast cancer in premenopausal women: fluke or fact?
    Pritchard KI
    Ann Oncol; 2006 Jul; 17(7):1035-6. PubMed ID: 16766581
    [No Abstract]   [Full Text] [Related]  

  • 18. Mammographic patterns in breast cancer chemoprevention with fenretinide (4-HPR).
    Cassano E; Coopmans de Yoldi G; Ferranti C; Costa A; Mascotti G; De Palo G; Veronesi U
    Eur J Cancer; 1993; 29A(15):2161-3. PubMed ID: 8297658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast conserving surgery for breast cancer involving the nipple.
    Carty H; McCullough P; Aluwihare N; Matey P
    Breast; 2008 Feb; 17(1):107-10. PubMed ID: 17892937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenretinide and cancer prevention.
    Torrisi R; Decensi A
    Curr Oncol Rep; 2000 May; 2(3):263-70. PubMed ID: 11122852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.